FDA Adverse Event Injury Summary report: N

DAVINCI XI

MDR report key: 15442922 · Received September 17, 2022

Report

Report Number
2955842-2022-14043
Event Type
Injury
Date Received
September 17, 2022
Report Date
August 18, 2022
Manufacturer
INTUITIVE SURGICAL, INC
Product Code
NAY
PMA / PMN Number
K131861
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

BASED ON THE CURRENT INFORMATION PROVIDED, THE CAUSES OF THE OPERATIVE COMPLICATIONS CANNOT BE DETERMINED. THERE IS NO ALLEGATION OR REPORT OF A MALFUNCTION OF A DA VINCI SYSTEM, INSTRUMENT, OR ACCESSORY. A FOLLOW-UP MDR WILL BE SUBMITTED IF ADDITIONAL INFORMATION IS OBTAINED. A SYSTEM LOG REVIEW COULD NOT BE PERFORMED DUE TO A LACK OF SYSTEM, PROCEDURE, AND INSTRUMENT DETAILS. NO IMAGE OR VIDEO CLIPS FOR THE REPORTED EVENT WERE SUBMITTED BY THE CUSTOMER FOR REVIEW. THIS COMPLAINT IS BEING REPORTED DUE TO THE FOLLOWING CONCLUSION: WITHIN THE JOURNAL ARTICLE TITLED, ¿LAPAROSCOPIC VERSUS ROBOTIC ADRENALECTOMY IN PHEOCHROMOCYTOMA PATIENTS,¿ IT IS NOTED WITHIN THE RA GROUP THAT THERE WAS ONE CONVERSION TO OPEN SURGERY DUE TO AN INABILITY TO OBTAIN ADEQUATE SURGICAL EXPOSURE AND MAKE PROGRESS DURING THE CASE. OPERATIVE COMPLICATIONS OCCURRED IN 4 ADDITIONAL PATIENTS WITHIN THE RA GROUP. THE COMPLICATIONS INCLUDED URINARY TRACT INFECTIONS (N=2), PNEUMONIA (N=1) AND VOLUME OVERLOAD (N=1). DURING A FOLLOW-UP PERIOD, ONE PATIENT DEVELOPED A RECURRENCE INVOLVING THE OPPOSITE ADRENAL GLAND AND ANOTHER PATIENT HAD A MULTIFOCAL SYSTEMIC RECURRENCE. THERE WAS ALSO ONE PHEOCHROMOCYTOMA-RELATED DEATH IN THE ROBOTIC GROUP INVOLVING A PATIENT WHO DEVELOPED SYSTEMIC METASTASES. THE CAUSES OF THE OPERATIVE COMPLICATIONS ARE UNKNOWN. NOTE: REFER TO MEDWATCH REPORT (MDR) WITH PATIENT IDENTIFIER (B)(6) FOR MDR SUBMISSION OF THE PATIENT DEATH NOTED IN THE RA GROUP WITHIN THE ARTICLE.

Description of Event or Problem · 0

ON 18-AUG-2022, INTUITIVE SURGICAL, INC. (ISI) BECAME AWARE OF A JOURNAL OF SURGICAL ONCOLOGY ARTICLE TITLED, ¿LAPAROSCOPIC VERSUS ROBOTIC ADRENALECTOMY IN PHEOCHROMOCYTOMA PATIENTS¿ (ISIKTAS, G., AVCI, S., ET AL., 2022). STUDY DATA WAS RETROACTIVELY COLLECTED FROM MARCH 2000 THROUGH OCTOBER 2021 WITH A TOTAL OF 157 PATIENTS (RA: N=87, LA: N=70). THE PURPOSE OF THE STUDY WAS TO COMPARE PERIOPERATIVE OUTCOMES OF LAPAROSCOPIC ADRENALECTOMY (LA) VERSUS ROBOTIC ADRENALECTOMY (RA) FOR PHEOCHROMOCYTOMA. WITHIN THE JOURNAL ARTICLE, A CONVERSION INVOLVING A DA VINCI SURGICAL PROCEDURE IS NOTED. PER THE ARTICLE, THERE WAS ONE CONVERSION TO OPEN SURGERY IN THE RA GROUP DUE TO AN INABILITY TO OBTAIN ADEQUATE SURGICAL EXPOSURE AND MAKE PROGRESS DURING THE CASE. ADDITIONALLY, WITHIN THE JOURNAL ARTICLE, POST-OPERATIVE COMPLICATIONS OCCURRED IN 4 PATIENTS FROM THE RA GROUP. COMPLICATIONS INCLUDED URINARY TRACT INFECTIONS (N=2), PNEUMONIA (N=1) AND VOLUME OVERLOAD (N=1). PATIENTS WERE FOLLOWED UP FOR A MEDIAN OF 60 MONTHS. DURING THIS FOLLOW-UP, ONE PATIENT DEVELOPED A RECURRENCE INVOLVING THE OPPOSITE ADRENAL GLAND AND ANOTHER PATIENT HAD A MULTIFOCAL SYSTEMIC RECURRENCE IN THE ROBOTIC GROUP. THERE WAS ONE PHEOCHROMOCYTOMA-RELATED DEATH IN THE ROBOTIC GROUP INVOLVING A PATIENT WHO DEVELOPED SYSTEMIC METASTASES. FOR THE PATIENT REFERENCED IN THE ARTICLE WITH THE REPORTED CONVERSION TO OPEN IN THE RA GROUP, THE AUTHOR REPORTED THAT THE EVENT WAS NOT RELATED TO THE DA VINCI SYSTEM AND THE SYSTEM WORKED WELL. THE AUTHOR EXPLAINED THAT IT WAS RELATED TO A TUMOR WITH INFILTRATION INTO SURROUNDING TISSUES MAKING THE PROGRESS DIFFICULT. PER THE AUTHOR, ¿SOMETIMES, WE HAVE DIFFICULT CASES IN CHALLENGING TUMORS AND PATIENTS.¿ THERE WAS NO REPORTED PATIENT HARM OR INJURY. PER THE AUTHOR, THERE WERE NO COMPLICATIONS AND NO ADVERSE EVENTS. ALSO, THE AUTHOR INDICATED THAT THERE WAS NO MALFUNCTION OF A DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
125811 DAVINCI XI PATIENT SIDE CART, 4-ARM NAY INTUITIVE SURGICAL, INC 380652 N/A

Patients

Seq Age Sex Outcome Treatment
1 Unknown DA VINCI INSTRUMENTS AND ACCESSORIES